
Brent R. Logan, PhD
Director & Professor, Biostatistics
Locations
- Biostatistics
Contact Information
Education
MS, Northwestern University, Evanston, IL, 1998
BS, Vanderbilt University, Nashville, TN, 1996
Research Experience
- Multiple Comparison Procedures
Research Interests
Dr. Brent Logan joined biostatistics in the summer of 2001. He has methodological research interests in multiple comparison procedures, clinical trial design, and survival analysis. Research in multiple testing includes methods for analyzing multiple endpoints in clinical trials, analysis of dose-response studies, and multiplicity adjustment in functional MRI studies. His interests in clinical trial design include randomized phase 2 clinical trials and biologic assignment trials in bone marrow transplant studies. Recent work in survival analysis has focused on inference for competing risks and multistate models using pseudo-value regression, analysis in the presence of crossing survival curves, and methods for the analysis of complex bone marrow transplant data. He is a biostatistician for the Blood and Marrow Transplant Clinical Trials Network (BMTCTN) and the Center for International Blood and Marrow Transplant Research (CIBMTR), as well as a statistical consultant for the National Marrow Donor Program.
Publications
-
(Levis MJ, Hamadani M, Logan BR, Jones RJ, Singh AK, Litzow MR, Wingard JR, Papadopoulos EB, Perl AE, Soiffer RJ, Ustun C, Oshima MU, Uy GL, Waller EK, Vasu S, Solh M, Mishra A, Muffly LS, Kim HJ, Stelljes M, Najima Y, Onozawa M, Thomson K, Nagler A, Wei AH, Marcucci G, Chen C, Hasabou N, Rosales M, Hill J, Gill SC, Nuthethi R, King D, Mendizabal A, Devine SM, Horowitz MM, Chen YB.) Blood. 2025 May 08;145(19):2138-2148 PMID: 39775763 01/08/2025
-
(Sorror ML, Saber W, Logan BR, Geller NL, Bellach A, Kou J, Wood WA, McCarty J, Knight TG, Runaas L, Johnston LJ, Walston JD, Nakamura R, Jarrett L, Mishra A, Uberti J, Dahi PB, Saultz JN, McCurdy SR, Morris LE, Imus P, Hogan WJ, Nadiminti KVG, Bhatt VR, Olin RL, Maakaron J, Sobecks RM, Wall SA, Mattila D, Protz B, Devine SM, Horowitz MM, Artz AS.) Blood Adv. 2025 Mar 18 PMID: 40101246 03/18/2025
-
Haploidentical Bone Marrow Transplantation for Sickle Cell Disease.
(Kassim AA, Walters MC, Eapen M, Smith M, Logan BR, Solh M, McKinney C, Nieder M, Ross M, Kent M, Abusin GA, Mallhi K, Silva JG, Shaughnessy P, Kanter J, Haines H, Farah R, Khaled YA, Ritzau N, Mendizabal A, Abraham A, Bollard C, Cooke K, de la Fuente J, Hanna R, Horowitz MM, Jordan LC, Bakshi N, Krishnamurti L, Leifer E, Mahadeo KM, Shenoy S, Jones RJ, DeBaun MR, Brodsky RA.) NEJM Evid. 2025 Mar;4(3):EVIDoa2400192 PMID: 39998298 PMCID: PMC11932095 02/25/2025
-
(Khanal M, Logan BR, Banerjee A, Fang X, Ahn KW.) Pharm Stat. 2025;24(1):e2464 PMID: 39846144 SCOPUS ID: 2-s2.0-85216016393 01/23/2025
-
(Spellman SR, Sparapani R, Maiers M, Shaw BE, Laud P, Bupp C, He M, Devine SM, Logan BR.) Blood Adv. 2024 Dec 10;8(23):6082-6087 PMID: 39368807 PMCID: PMC11652765 SCOPUS ID: 2-s2.0-85212173730 10/06/2024
-
(Hamilton BK, Pandya BJ, Ivanescu C, Elsouda D, Hamadani M, Chen YB, Levis MJ, Ueda Oshima M, Litzow MR, Soiffer RJ, Ustun C, Perl AE, Singh AK, Geller N, Hasabou N, Rosales M, Cella D, Corredoira L, Pestana C, Horowitz MM, Logan B.) Blood Adv. 2024 Oct 08;8(19):5091-5099 PMID: 39167766 PMCID: PMC11460446 SCOPUS ID: 2-s2.0-85206267504 08/21/2024
-
(Pasquini MC, Wallace PK, Logan B, Kaur M, Tario JD, Howard A, Zhang Y, Brunstein C, Efebera Y, Geller N, Giralt S, Hari P, Horowitz MM, Koreth J, Krishnan A, Landau H, Somlo G, Shah N, Stadtmauer E, Vogl DT, Vesole DH, McCarthy PL, Hahn T.) J Clin Oncol. 2024 Aug 10;42(23):2757-2768 PMID: 38701390 PMCID: PMC11634105 SCOPUS ID: 2-s2.0-85201029574 05/03/2024
-
(Levis MJ, Hamadani M, Logan B, Jones RJ, Singh AK, Litzow M, Wingard JR, Papadopoulos EB, Perl AE, Soiffer RJ, Ustun C, Ueda Oshima M, Uy GL, Waller EK, Vasu S, Solh M, Mishra A, Muffly L, Kim HJ, Mikesch JH, Najima Y, Onozawa M, Thomson K, Nagler A, Wei AH, Marcucci G, Geller NL, Hasabou N, Delgado D, Rosales M, Hill J, Gill SC, Nuthethi R, King D, Wittsack H, Mendizabal A, Devine SM, Horowitz MM, Chen YB, BMT-CTN 1506/MORPHO Study Investigators.) J Clin Oncol. 2024 May 20;42(15):1766-1775 PMID: 38471061 PMCID: PMC11095884 SCOPUS ID: 2-s2.0-85193456124 03/12/2024
-
(Sparapani RA, Maiers M, Spellman SR, Shaw BE, Laud PW, Devine SM, Logan BR.) medRxiv. 2024 May 09 PMID: 38766030 PMCID: PMC11100939 05/20/2024
-
(Grunebaum E, Arnold DE, Logan B, Parikh S, Marsh RA, Griffith LM, Mallhi K, Chellapandian D, Lim SS, Deal CL, Kapoor N, Murguía-Favela L, Falcone EL, Prasad VK, Touzot F, Bleesing JJ, Chandrakasan S, Heimall JR, Bednarski JJ, Broglie LA, Chong HJ, Kapadia M, Prockop S, Dávila Saldaña BJ, Schaefer E, Bauchat AL, Teira P, Chandra S, Parta M, Cowan MJ, Dvorak CC, Haddad E, Kohn DB, Notarangelo LD, Pai SY, Puck JM, Pulsipher MA, Torgerson TR, Malech HL, Kang EM, Leiding JW.) J Allergy Clin Immunol. 2024 May;153(5):1423-1431.e2 PMID: 38290608 PMCID: PMC11070290 SCOPUS ID: 2-s2.0-85185611997 01/31/2024
-
Statistical rules for safety monitoring in clinical trials.
(Martens MJ, Logan BR.) Clin Trials. 2024 Apr;21(2):152-161 PMID: 37877375 PMCID: PMC11003847 SCOPUS ID: 2-s2.0-85174803819 10/25/2023
-
Sequential monitoring of time-to-event safety endpoints in clinical trials
(Martens MJ, Lian Q, Geller NL, Leifer ES, Logan BR.) Clinical Trials. 2024 SCOPUS ID: 2-s2.0-85213536554 01/01/2024